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Experience of Care 
 
Conceptualising multiple conditions in Australia: First steps to systemic 
change to meet the needs of people with serious long-term illnesses 
 
Christine Walker, Chronic Illness Alliance, cwalker@chronicillness.org.au 
 
 
Abstract 
Since the 1970s greater numbers of people are now living with several serious long term illnesses. These include rarer 
genetic conditions and ‘lifestyle conditions’ as well as those of an idiopathic nature. This article examines the growing 
need for new terms and concepts that reflect the changes in the lives of people living with long-term serious illnesses. 
Members of the Chronic Illness Alliance attended a workshop where they presented their experiences and views of 
living with multi-morbidities. Consumers were concerned about treatment side-effects, polypharmacy, adverse events 
and the need for coordinated care. Following this workshop, the Chronic Illness Alliance undertook a literature review 
using the principles of meta-synthesis to explore the consumer perspective in literature on multi-morbidities. This 
method aims to systematise qualitative concepts and it provided the means to identify whether the concerns raised by 
consumers were recognised in the literature. The risks identified by consumers were used both as search terms and 
analytical terms. While the consumer perspective appeared absent in the literature, many authors showed similar concern 
about the tardiness of health systems to acknowledge the impact of multi-morbidities for consumers and the associated 
risks. More importantly the literature review demonstrated that problems associated with concepts, definitions and data 
collection impact on health care and service delivery. This in turn dictates how consumers receive their health care 
services and ultimately influences the safety and quality of their health care. The article discusses the concepts of co-
morbidity and multi-morbidity in relation to data collection, definitions and treatment guidelines and their implications 
for consumers with regard to treatments, side-effects, polypharmacy, adverse events and coordinating care. There is a 
pressing need to develop and employ concepts that better reflect consumers’ needs and experiences in order to improve 
safety and quality of health care. The article argues that the adoption of better concepts is a first step to achieving 
systemic change on behalf of people with multiple conditions. 
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Introduction 
 
This article examines the growing need for new terms and 
concepts that reflect the changes in the lives of people 
who are now living with long-term serious illnesses for far 
longer periods. The article articulates the needs of people 
living with long-term serious illnesses from health services 
and health policies to ensure that care is designed to 
promote as high a quality of life as possible. Overall the 
aims of this study are to articulate the needs of people with 
multiple conditions, the problems they face in the current 
health services context in Australia and to explore how 
people with multiple conditions might be better assisted.  
 
Background  
 
Griff is now in his early 60s. He retired some 8 years ago 
following a career in administration. He and his wife lead a 
life of social activity, family responsibilities and community 
involvement. While this might lead us to applaud Griff’s 
decision to plan for an early retirement there is much more 
in Griff’s life for us to contemplate. Griff has hemophilia, 
which means a lifetime of replacement therapy and care at 
a specialist treatment centre. In Griff’s case it has also 
meant musculoskeletal conditions associated with the joint 
damage caused by bleeds, and consequent surgery to many 
of his joints. He also developed Hep C from contaminated 
blood products supplied to him several decades ago. The 
fatigue of, and treatment for Hep C led to years of 
depression. Griff also has asthma, epilepsy and 
osteoporosis. Griff’s working life and retirement has been 
punctuated by the time he spends at treatment centres and 
the money it costs in co-payments, transport and health 
insurance. Both he and his wife are fully aware of the value 
of having health professionals with understanding of the 
full range of his conditions and their treatments involved 
in his care and that this may sometimes be difficult to find. 
In many ways Griff’s life encapsulates the problems 
associated with living with multiple conditions.  It also 
suggests the path of health reform to deal adequately with 
these issues in the 21st century. Firstly such a path requires 
the means to capture the changing patterns of disease.  
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It is only relatively recently that health service research has 
recognised that data collection provides a means to 
improve service delivery through recognition of changing 
patterns of disease. Alvin Feinstein was a pioneer of this 
approach 1.  
In 1970 Feinstein developed the concept of co-morbidity. 
Feinstein maintained that co-morbidity referred to ‘any 
distinct additional clinical entity that has existed or that 
may occur during the clinical course of a patient who has 
the index disease under study’.  
Feinstein’s aim in elucidating these complexities was to 
provide a guide to both epidemiologists and clinicians. He 
argued that the lack of acknowledgment of co-morbidities 
had consequences for the collection of accurate statistics 
of diseases such as mortality rates and fatality rates for 
individual diseases. 
Where clinicians were concerned Feinstein argued that 
ignoring co-morbidities impacted on the accurate 
evaluation of treatment. The customary evaluation of 
treatment by studying comparable groups of patients, 
usually in a single disease clinical trial, that excluded people 
with co-morbidities meant the results did not fit the ‘real 
world’. Additionally, not recognizing the presence of co-
morbidities affected the accurate diagnosis and treatment 
of an index disease, since co-morbidity could mask the 
index disease, thus delaying its diagnosis and appropriate 
treatment and ultimately impacting on the outcome of the 
index disease.  
Feinstein’s conceptual work has been integrated into the 
prevention, diagnosis, and treatment of many chronic 
illnesses such as type 2 diabetes, chronic obstructive 
pulmonary disease and chronic heart conditions, 
particularly in ageing populations. Since the 1970s however 
a major change has taken place whereby more people are 
living longer with chronic illnesses 2. This includes living 
longer with rare genetic illnesses, lifestyle-related 
conditions and idiopathic conditions 3, 4.  In the 25 years 
from1973 to 1998, the survival of children with Cystic 
Fibrosis (CF) increased by seven hundred per cent while 
the survival of children with congenital heart disease had 
increased by three hundred per cent 5. Whereas young 
people with genetic conditions such as CF had a life 
expectancy of about 18 years in the 1970s, young people 
now are graduating from tertiary institutions, marrying and 
having children. Cystic-fibrosis related diabetes has been a 
known co-morbid condition for some 50 years, but it is 
now a far greater problem for those who must live with it 
for some decades arising as it does as a result of the high 
fat diets, which assist people surviving CF 6. In 2006 it was 
found that some sixty per cent of the US population aged 
over 18 had at least one chronic condition but this 
increases with age so that in the 65 and over age group 
three out of four people have multiple chronic conditions 
7. The authors noted in 2005: 
 
‘The proportion of adults with at least one 
chronic condition increased dramatically with 
age, ranging from 36.4 per cent of young adults 
age 18–34 to 91.5 per cent of the elderly age 
65 and over. The proportion of persons with 
two or more chronic conditions also rose 
dramatically with age, ranging from only 14.4 
per cent among persons age 18–34 to 76.6 per 
cent of the elderly age 65 and over.’7 
 
These statistics demonstrate that where lives might have 
been shortened by serious conditions in the past, people 
are now living much longer with those conditions and the 
longer they live the greater the likelihood of contracting 
other conditions. Much has been written on the costs to 
health systems of these changes and the need for health 
services to work with the changing profiles of ageing and 
chronic illnesses. However little has been written of the 
experience of living with more than one condition, the 
effects of treatments and how this compounds on people’s 
quality of life. 
 
As stated at the beginning this article examines the 
growing need for new terms and concepts that reflect the 
changes in the lives of people who are now living with 
long-term serious illnesses for far longer periods, because 
they are most likely the ones to develop multiple 
conditions. By articulating their needs and the problems 
they face in the current health services context in Australia 
new concepts and terminology can contribute to the 
development of health services and policies that work for 
people with multiple conditions.  
  
Methods 
 
Ethical approval 
Ethical approval was sought subsequent to the workshop 
being undertaken and was provided by the Human 
Research Ethics Committee 2013/223 of Deakin 
University Australia, which determined that the project 
complied with the Australian National Statement on 
Ethical Conduct in Human Research (2007). Written 
informed consent is obtained for every workshop 
participant all of whom were over the age of 18, and able 
to comprehend the Plain Language Statement and Consent 
Forms. 
 
Defining the problems faced by consumers 
In 2008 members of the Chronic Illness Alliance, an 
Australian peak body which aims to build a better focus 
for all people with chronic illnesses in Australian health 
policy and health services held a workshop with its 
members to discuss the impact of living with ‘more than 
one condition’. The workshop participants decided to refer 
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to this issue as ‘multiple conditions’ and the Alliance has 
retained this term instead of the terms multi-morbidities or 
multiple morbidities current in medical literature 8.  
Participants had illnesses such as MS, Cystic Fibrosis, 
Thalassaemia, types1 and 2 diabetes, depression, 
osteoarthritis and epilepsy. In all cases participants had 
other conditions as well as these index conditions.  They 
collectively identified that people with multiple conditions 
were at risk of adverse events and unwanted 
complications. Their risks were related to: 
 
 The number of medications they require, some of 
which may lead to drug interactions. An example of 
this is the interaction between some antiretrovirals 
and anti-epileptic drugs 9. Additionally, medicines for 
one condition may lead to acquiring another 
condition such as treatment levels for hypothyroidism 
predisposing older people to osteoporosis 10. 
Similarly, blood transfusions in Thalassaemia major 
can lead to liver failure 11.   
 The unknown implications of treatments. In some 
cases treatment for a cancer may cause another cancer 
to develop many years later. 
  Confusion over the diagnosis (such as health 
professionals in Emergency Departments confusing 
treatment of type 1 diabetes with treatment of Type 2 
diabetes.) 12 
 The competing needs of caring for a number of 
different diagnoses in the one person where there is a 
need to prioritise which diagnosis is the most 
important one to concentrate on. 
 The difficulty of accessing medical services where the 
person’s entire medical situation is fully understood.  
 People with multiple conditions are likely to be 
stressed, both financially and emotionally. Their 
ability to work may suffer; the costs of their care are 
likely to be far greater than others. The time required 
to self-care will contribute to this stress. They may be 
more socially isolated which contributes to stress and 
depression. 
 
Workshop participants argued that these problems arose 
because health systems had not caught up with their 
changing needs. They considered new terms were needed 
to cover the complexity of living with more than one 
condition and a new definition was required. They 
requested the Chronic Illness Alliance conduct a literature 
search to explore if consumer experiences of living with 
multiple conditions were represented in health service 
literature.  
 
Data Collection 
Using the risks identified by workshop participants as the 
search term parameters, the aim of the literature review 
was to identify issues related to consumer concerns; 
definitions and concepts of multiple conditions; any work 
undertaken to reduce the risks that concern consumers 
with multiple conditions. Search methods associated with 
systematic literature searching and article identification 
were employed to enhance the quality of the work. 
Medline, CINAHL, Google Scholar and Cochrane Library 
databases were searched for the period 2000 to 2009. Only 
English language journals were searched.  
 
‘Multiple conditions’ is not used in medical and health 
service literature. It remains here, as it is the term agreed 
by the Multiple Conditions Workshop participants as the 
most reflective of their experiences. An initial search on 
consumer issues and perspectives in multiple conditions 
produced no results. It was necessary to adopt MeSH 
terms in order to search the literature. The following terms 
were used: multi-morbidity; multiple chronic conditions; 
multiple co-morbidities; multiple morbidities; multiple 
medical conditions; complex chronic disease; complex care 
patient.  
 
Two research assistants reviewed abstracts independently. 
Inclusion related to how well abstracts met the search term 
criteria relating to multiple conditions, co-morbidities, 
consumer experiences and perspectives, safety and quality, 
definitions of terms, primary care and specialist services, 
coordinated care, risks and benefits of treatments, care of 
rare conditions and the relation between multiple 
conditions and depression. Full tests were assessed by the 
author in association with the research assistants. Inclusion 
criteria related to those articles that addressed issues of 
coordinated or uncoordinated care, polypharmacy, adverse 
events, discussions of multiple chronic illnesses and how 
these were being addressed in health services and policies, 
the consumer perspective of living with multiple 
conditions. There were no articles that focused on the 
consumer experience of living with multiple conditions. 
From a total of 40,000 articles 88 articles met the 
consumer-driven criteria. This was a purposive sample of 
articles as the approach was a qualitative one based on the 
more recent methods of meta-synthesis, discussed below.  
 
Data analysis 
The consumer-derived aims indicated a qualitative 
approach was appropriate since needs of the consumers 
were more likely to be answered by what Harden et al 
describe as ‘intervention studies’ that ‘identify effective, 
ineffective and harmful interventions’ and ‘non-
intervention’ studies that discuss systemic issues associated 
with the quality of services consumers receive 13. 
Systematising qualitative work is a relatively new area 
where methods are still being developed and discussed 14. 
Harden et al  and Thomas and Harden  describe their 
method as: beginning with the research question; 
conducting a systematic search for intervention and non-
intervention studies and then holding a stakeholder 
consultation which refined questions; followed by in-depth 
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review of those studies that were included 13 ,15.  In-depth 
review was conducted according to the application of 
inclusion criteria. The final stage of their process was a 
synthesis of findings from the studies to answer the 
questions they had begun with. As a qualitative method 
this process does not rely on an exhaustive search as in 
systematic reviewing. Instead it is a purposive search for 
key or common concepts across studies from which to 
develop an argument 15.  
This project on multiple conditions began with the 
consumer consultation which defined their problems and 
established that consumers wanted to know what, if any 
work, was being undertaken that would address these 
problems. Thus the consultation delineated the above-
mentioned aims, the inclusion criteria for literature and 
provided consumer-driven terms from which to analyse 
the data.  
While Harden et al established quality criteria for inclusion 
of articles such as whether an article had a theoretical 
framework or clearly described the methods; this project 
had a different intention to that of assessing the quality of 
evidence. 13 Identifying the recent trends in thought about 
the care of multiple conditions can be seen as a 
preliminary step to that of any discussion of quality. 
With regard to the analysis of data, the 88 articles selected 
were not exhaustive; this was a purposive sample since in 
qualitative analysis the purpose is interpretive rather than 
predictive .16 Working from principles of grounded theory 
where the contents of articles speak for themselves, 
coding, based on the above consumer-derived terms was 
undertaken with each article .17 These were then combined 
into themes which emerged as: problems of terminology, 
data and prevalence of multiple conditions; problems of 
multiple conditions for health services and the care of 
people with multiple conditions including quality and 
safety issues and coordinating care. These themes are 
recorded below as the results.  
Results  
 
The results provided here are not quantifiable but the 
results of qualitative analysis. No articles were written 
from the perspective the consumer living with multiple 
conditions. However many of the problems experienced 
by workshop participants are discussed in the literature 
from the perspective of the quality of health service 
delivery. These discussions fall under the broad categories 
of accurate data and collection; accurate definitions; issues 
of disease-specific guidelines.  
 
The problems of accurate data and data collection 
Several articles focus on the prevalence of multiple 
conditions in primary care and the implications this 
prevalence poses for good care. 18, 19, 20, 21  In Canada it was 
estimated that multiple conditions are most common in 
older people with some 98% of older people in a single 
Canadian sample having multiple conditions. 18, 22 The 
authors also demonstrate that multiple conditions exist in 
younger age groups, with a prevalence of 69% in 18-44 
year olds, 93% in 45-64 year olds in a sample of Quebec 
family practices. Another article also identified that 
multiple conditions were a problem in younger adults.23 
These inconsistencies relate to not having access to 
consistent data. The problems associated with multiple 
conditions were identified as a greater likelihood of dying 
prematurely, more hospital admissions and longer hospital 
stays, a poorer quality of life including poor physical 
functioning, depression and all the associated problems of 
polypharmacy as well as interactions between treatment 
for one condition and treatments for other conditions. 20, 
24 
 
Researchers interested in exploring these issues have been 
beset by problems of data collection. Current forms of 
disease classification and coding create barriers to the 
research and care of people with multiple conditions. 23 
Disease coding may be variable while GP software is not 
helpful due to the different products and platforms that do 
not allow for sharing of data. Researchers in Germany 
undertook analyses of the health utilisation patterns of 
nearly 40,000 people with co-or multi-morbidities and 
consider that data structure is an essential means to build a 
basis to understand the needs and health utilisation of 
people with co-morbid or multiple conditions. 25 
 
Data may not be valid. In Canada the problem with valid 
data on the extent of multi-morbidity in family practices in 
Canada continues to hold back research on its prevalence, 
allowing only estimates. 18 By counting the number of 
conditions and using a severity rating scale the authors 
found that multiple conditions are more common in 
primary care than are single conditions. While the 
Charlson Co-morbidity Index (CCI) may be used to 
determine the association between medical co-morbidity 
and the number of tests for related conditions researchers 
concluded that more research was required to determine 
whether all patients with varying co-morbid illness burdens 
should receive equally aggressive care as it was difficult to 
determine if all equally benefited. 26   Application in 
Australia of the Cumulative Illness Rating Scale (CIRS) to 
Australian data drew comments on its limitations in 
comparing data from other studies. 21  
 
The problem of accurate definition 
Problems of disease classification and data collection are 
interconnected with definitions and concepts. Firstly co-
morbidity itself is not necessarily a simple term. A review 
that investigated the use of co-morbidity in health sciences 
literature from 1966 to 1994 pointed out the lack of 
consensus regarding the use of the concept. 27 Attempts to 
study the impact of co-morbidity are complicated by the 
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lack of consensus on how to define the concept, which 
leads to problems in measuring its impact.28  The authors 
also note that co-morbidity and multi-morbidity may be 
used interchangeably. Following the influence of 
Feinstein’s seminal definition, several studies have 
demonstrated that most studies between 1993 and 1997 
investigated co-morbidity from the perspective of a 
specific or index disease, most commonly cardiovascular 
diseases (48%), cancers (23%), musculoskeletal diseases 
(13%), or diabetes (11%). 27, 29 
 
Secondly, while measuring co-morbidity has advanced our 
understanding, some authors conclude that the term multi-
morbidity, defined by others as the ‘co-occurrence of two or 
more diseases within one person, without defining an 
index-disease’ 27 is a better means to study the complexity 
that is associated with having more than one condition. 27, 
29 
 
Others have attempted definition of the terms multiple 
morbidities or multi-morbidities. Fortin et al 30 define 
multi-morbidity as multiple coexistent diseases; Mercer et 
al 31 define multi-morbidity as the co-existence of two or 
more long-term conditions in an individual; Ritchie 32 
defines multi-morbidity as the ‘simultaneous existence of 
more than one pathophysiologic condition or clinical 
entity’; Min et al defines multi-morbidity as multiple 
coexisting chronic conditions 33.   
 
Issues related to disease-specific guidelines 
Where there are either co-morbidities or multiple 
conditions disease specific guidelines cause more problems 
than they solve, leading to adverse events, including drug 
interactions.19 Adherence to guidelines in patients with 
more than two chronic conditions may not be possible due 
to inconsistencies in recommendations across multiple 
diagnosed conditions.34 Other arguments emphasise that it 
is no longer realistic  to apply single disease guidelines to 
the care of people with multiple conditions as it does not 
leave enough time in primary care to care for all their 
needs.35  At the same time, multi-morbidity exposes people 
to more adverse events, fragmentation of care and 
contradictory health care recommendations. 32 In addition 
payment structures in the Australian health system as well 
as other health systems reinforce the commitment to 
single disease guidelines. 21 
 
Discussion 
 
Problems of disease classification and data collection, 
which extend to the definition and terminology, were 
identified by workshop participants as pertinent to how 
their multiple conditions are managed. Regardless of 
whether conditions are co-morbid or multiple, conflicting 
definitions and lack of data influence the care of people. 
There are disagreements over how care is influenced by 
this conflict. For example, some research demonstrates 
that multiple conditions are associated with poor 
outcomes, decreased quality of life, psychological distress, 
more frequent hospital admissions and longer stays, post-
operative complications, higher cost of care and higher 
mortality 36. But the opposite viewpoint arises when others 
explored the time factors as well as numerous guidelines 
and concluded patients with greater multi-morbidity 
received better care than would be expected when based 
on the specific set of quality indicators they triggered. 33 
Additionally other findings suggest that the quality of care 
increased as the number of conditions increased with little 
need to adjust for the difficulty of delivering the care. 37  
 
Guidelines and evidence-based practice are based on single 
conditions constituting a barrier to care of multiple 
conditions. 24 The lack of articles on multi-morbidities and 
their diversity demonstrates an insufficient evidence-base 
for the care of people with multi-morbidities. Fortin who 
found that for every article on multi-morbidity there were 
74 on asthma, 94 on hypertension and 38 on diabetes 
underscores this point. 18 
 
However in the workshop people with multiple conditions 
argued from their own experiences that they struggled to 
receive care coordinated between specialists, general 
practice (or family practice) and hospital care. Some 
argued that whilst they received good care for their index 
condition, another condition might be causing them 
greater concern. Often it was hard to find care for a co-
morbid condition. Others pointed out that they personally 
had to ensure treatments they were offered would not 
interact with other treatments. It was important to have 
enough knowledge to be able to make decisions around 
‘trade-offs’ in treatments where the benefits of treatment 
for one condition might interact with treatment for 
another condition.  
 
One area of concern to workshop members that receives 
little attention in the literature on multi-morbidities relates 
to rare conditions. Although individual conditions may be 
rare in epidemiological terms (defined by the US Orphan 
Drugs Act as disease affecting less than 200,000 persons in 
the US or in Europe as one that affects less than five in 
10,000) there are a great number of them. 38 The European 
Organisation for Rare Disease (EURORDIS) estimates 
there are between 5000 and 8000 rare conditions affecting 
as many as 30 million Europeans. Rare conditions may be 
terminal, chronic, progressive and disabling; many have 
genetic origins. Rare conditions may mean a person has 
difficulty receiving a correct diagnosis; delays in receiving a 
correct diagnosis may lead to complications, or lack of 
access to appropriate treatment including multidisciplinary 
care. 38 EURORDIS argues that the consequences of these 
difficulties and delays have hardly been researched, 
pointing to the problems that exist in data collection and 
classification of many rare conditions.  At the same time 
and despite great advances in their care, rare conditions 
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often have complications related to treatment including 
side-effects of treatments and adverse effects from 
inappropriate treatment or inappropriately prescribed 
treatments.  Treatments themselves may give rise to new 
conditions rather than simply giving rise to complications. 
For example, type 2 diabetes can occur in Thalassaemia 
and Cystic Fibrosis as a side effect of treatment. 
 
Most rare conditions are the domain of specialist care, an 
outcome of the historical growth of care of single 
conditions, which compounds the poor coordination of 
care. However people with rare conditions see general 
practitioners as well. This might be for a range of reasons; 
treatment for a common cold; the renewal of a 
prescription or care of another condition. Lack of 
communication between specialists and generalists might 
cause inconvenience or pose a danger to the person’s life.  
 
Workshop participants, many of whom had rare 
conditions, had had direct experience of these issues. In 
some instances, participants were better informed about 
their condition and treatments than were the health 
professionals. Others such as people with type 1 diabetes 
had been provided incorrect treatment as persons with 
type 2 diabetes in emergency departments of large 
hospitals. Participants claimed it was far safer that they, or 
a family member, were in charge of coordinating their care 
than health professionals. In Griff’s case he had 
‘interviewed’ GPs before choosing someone who was 
willing to ‘take the journey alongside him’ and who 
respected his personal expertise in hemophilia. On the 
other hand Griff found that after developing Hepatitis C 
many of the health professionals he saw were more likely 
to focus on that condition than his other conditions, 
including the immediate reason for attending. It was also 
many years before his struggles with fatigue, poor 
motivation and lack of interest in life were identified as 
depression and he was treated for this. Part of Griff’s 
recovery was self-administered through writing out his 
journey through illness towards a level of reconciliation 
with his lived experience. 
 
Unfortunately for Griff and the consumers like him the 
research literature provided few suggestions on the health 
service reforms needed to better meet the needs of people 
with multiple conditions. However, those researchers who 
are aware of the problems that multi-morbidities create for 
health services as well as for those who live with them 
have a number of avenues to explore. Firstly and of 
greatest importance, research that addresses the 
shortcomings of funding the care of single conditions and 
promotes relevant reforms will drive changes. Issues 
related to safety of health care, especially with regard to 
adverse events related to polypharmacy, are also likely to 
drive research and reform. E-health is likely to provide 
pathways to enable health services to better grasp 
relationships between conditions and treatment 
interactions.  
 
Consumers in the workshop argued that their multiple 
conditions should be regarded as ‘portfolios’. This 
portfolio approach would include specification of how 
each condition was interrelated. For example it would 
specify whether a condition was co-morbid, or iatrogenic 
or idiopathic. A portfolio could also build up individual 
guidelines that related to the combinations of each 
condition for that individual avoiding disease-specific 
guidelines and moving away from the perspective of the 
index condition if this were not applicable in a specific 
case.  
 
Underlying any new approach is the need for new 
definitions and classifications related to multiple 
conditions.  
 
Conclusions  
 
People are now living longer with chronic conditions and 
are also developing new ones. Increasing age and survival 
rates are likely to lead to more conditions, which may be 
co-morbid or unrelated. Members of the Chronic Illness 
Alliance who attended a workshop on multiple conditions 
identified the need for new concepts to meet their health 
care needs. The needs they identified relate to 
polypharmacy, safety and quality issues related to adverse 
events, diagnosis, coordinated care including prioritising 
care and finally their own quality of life issues which 
includes the numerous stresses of living with multiple 
conditions.  
 
While literature around multi-morbidities is largely 
concerned with problems arising in health services, many 
of the issues identified are equally of concern to people 
living with multi-morbidities. This literature identified the 
problems that create barriers to improving the system for 
the mutual benefit of health services and consumers. 
These problems are concerned with data collection and 
disease classification. As Feinstein noted with regard to 
accurate data collection on co-morbidities the need was to 
reflect the ‘real world’. This would lead to better care of 
the whole person as well as a better understanding of 
patterns of mortality and morbidity. Feinstein’s work 
provides a starting point for further research into multi-
morbidities.  
 
The continued conception of single disease guidelines and 
health funding systems that reimburse for the care of 
single conditions are major impediments to working 
effectively with people who have multiple conditions that 
cannot be assumed to fall under the umbrella term ‘co-
morbid’.  
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Fortunately for consumers, work in this area has begun, 
with a number of researchers recognising that care based 
on single diseases leads to continued barriers to full care as 
well as amplifying the risks of adverse events. Some 
researchers are considering the need to develop new 
definitions of multi-morbidity in recognition of the 
changing pattern of disease in the 21st century.  
 
This literature review revealed that despite the consumer 
perspective being absent from the literature on multiple 
conditions, consumers and health service providers had 
similar concerns about the improvements that should be 
made to assist people with multiple conditions. The 
challenge represented by multiple conditions for both 
researchers and consumers with multi-morbidities is to 
redesign health systems and the way they are funded. 
Opportunities exist now to apply new innovations such as 
e-health applications to enhance communications and 
address poor coordination of all the services required by 
people with multiple conditions. It is the author’s hope 
that this challenge will be met by health reformers and 
service providers partnering with consumers with multiple 
conditions so that innovations will eventually address 
consumers’ needs with regard to delivering a safer, 
reflexive system of care that is affordable and works to 
provide people with multiple conditions with better quality 
of life beyond the health system, while at the same time 
delivering safer, better coordinated services with fewer 
unplanned hospital admissions. The first step is 
conceptualising multiple conditions.  
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